Saydam, G. Et Al. 2022. The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.. International journal of hematologic oncology , vol.11, no.1 .

Saydam, G., Ali, R., Demir, A. M., Eskazan, A. E., Guvenc, B., Haznedaroglu, I. C., ... Ozcan, M. A.(2022). The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.. International journal of hematologic oncology , vol.11, no.1.

Saydam, Guray Et Al. "The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.," International journal of hematologic oncology , vol.11, no.1, 2022

Saydam, Guray Et Al. "The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.." International journal of hematologic oncology , vol.11, no.1, 2022

Saydam, G. Et Al. (2022) . "The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.." International journal of hematologic oncology , vol.11, no.1.

@article{article, author={Guray Saydam Et Al. }, title={The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.}, journal={International journal of hematologic oncology}, year=2022}